A Case of Asthenozoospermia Following COVID-19 Infection.
Asthenozoospermia
COVID-19
Case report
Male infertility
SARS-CoV-2
Journal
Reproductive sciences (Thousand Oaks, Calif.)
ISSN: 1933-7205
Titre abrégé: Reprod Sci
Pays: United States
ID NLM: 101291249
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
03
03
2022
accepted:
15
05
2022
pubmed:
24
5
2022
medline:
9
9
2022
entrez:
23
5
2022
Statut:
ppublish
Résumé
Studies pertaining to the effect of COVID-19 infection on male fertility are scarce. This case report describes a case of transient asthenozoospermia, absence of sperm motility, following a moderately severe COVID-19 infection. A couple presenting for infertility treatment due to low ovarian reserve presented for their second intrauterine insemination (IUI). Their first IUI was performed 1 month earlier when the semen parameters were normal. A couple of weeks before the second IUI, the unvaccinated 48-year-old male partner contracted COVID-19 and was admitted to the hospital for several days. He received IV Remdesivir and continuous oxygen by nasal cannula. His hospitalization did not require intubation or intensive care unit admission. He was discharged after 12 days of hospitalization without home oxygen treatment. On the day of the second IUI, the semen analysis showed a normal sperm count with 0% motility. Three months following his COVID-19 diagnosis, a repeat semen analysis showed restored normal parameters with more than 40% motility. This aim of this report is to increase awareness that moderate COVID-19 requiring hospitalization could affect, though temporarily, sperm motility and should be considered in the differential diagnosis when male infertility is encountered.
Identifiants
pubmed: 35606631
doi: 10.1007/s43032-022-00975-2
pii: 10.1007/s43032-022-00975-2
pmc: PMC9126095
doi:
Substances chimiques
Oxygen
S88TT14065
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2703-2705Informations de copyright
© 2022. Society for Reproductive Investigation.
Références
Jain U. Effect of COVID-19 on the organs. Cureus. 2020;12(8):e9540.
pubmed: 32905500
pmcid: 7470660
Gavriatopoulou M, et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;20(4):493–506.
doi: 10.1007/s10238-020-00648-x
Wesselink AK, et al. A prospective cohort study of COVID-19 vaccination, SARS-CoV-2 infection, and fertility. Am J Epidemiol. 2022. https://doi.org/10.1093/aje/kwac011 .
doi: 10.1093/aje/kwac011
pubmed: 35641149
pmcid: 8807200
Morselli S, et al. Male reproductive system inflammation after healing from coronavirus disease 2019. Andrology. 2021. https://doi.org/10.1111/andr.13138 .
doi: 10.1111/andr.13138
pubmed: 34889528
Gacci M, et al. Semen impairment and occurrence of SARS-CoV-2 virus in semen after recovery from COVID-19. Hum Reprod. 2021;36(6):1520–9.
doi: 10.1093/humrep/deab026
Guo TH, et al. Semen parameters in men recovered from COVID-19. Asian J Androl. 2021;23(5):479–83.
doi: 10.4103/aja.aja_31_21
World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 6th ed. Geneva: WHO Press; 2021. Accessed on 3 December 2021.
Mollica V, Rizzo A, Massari F. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Future Oncol. 2020;16(27):2029–33.
doi: 10.2217/fon-2020-0571
Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, Leydig and Sertoli cells. Cells. 2020;9(4):920. https://doi.org/10.3390/cells9040920 .
doi: 10.3390/cells9040920
pmcid: 7226809
Shen Q, et al. The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection. J Cell Mol Med. 2020;24(16):9472–7.
doi: 10.1111/jcmm.15541